CME Accredited

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Federation of American Societies for Experimental Biology (FASEB), the American Society for Investigative Pathology and the Association for Molecular Pathology. FASEB is accredited by the ACCME to provide continuing medical education for physicians.

FASEB designates this educational activity for a maximum of 30 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy
The Federation requires that audiences at FASEB-sponsored educational programs be informed of a presenter's (speaker, faculty, author, or contributor) academic and professional affiliation, and the existence of any significant financial interest or other relationship a presenter has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during the presentation, it is required that presenters disclose that the product is not labeled for the use under discussion or that the product is still investigational. This policy allows the listener/attendee to be fully knowledgeable in evaluating the information being presented.

Disclosure includes any relationship that may bias one's presentation or which, if known, could give the perception of bias. These situations may include, but are not limited to: 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) research grants; 3) employment (full or part-time); 4) ownership or partnership; 5) consulting fees or other remuneration; 6) non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson; 7) receipt of royalties; 8) speaker's bureau; 9) other. For full-time employees of industry or government, the affiliation listed in the Program will constitute full disclosure.

CME application forms will be available from the AMP Administrative Office, 9650 Rockville Pike, Bethesda, MD 20814, 301-634-7939; email: mherrera@asip.org. For the purposes of Continuing Medical Education credits toward the American Medical Association Physician's Recognition Award, the AMP 2008 Meeting is jointly sponsored by the American Society for Investigative Pathology and the Federation of American Societies for Experimental Biology. For more information, please contact the FASEB Office of Scientific Meetings and Conferences at 301-634-7010.

Meeting Objective/Target Audience
The objective of this meeting is to provide a forum for the exchange of the latest advances in molecular pathology by laboratory professionals and investigators. At the completion of this meeting, participants should be able to explain the biologic basis and the utility of molecular diagnostic systems, know which tests are under development and show promise for diagnosis and prognosis that can lead to improvements in human health, and understand regulations that govern the development and use of molecular genetic tests for the safety of patients and research subjects. This meeting is targeted to clinical practitioners, research scientists and medical education professionals with an interest in the development and evaluation of new molecular genetic diagnostic tests using molecular biology methodology.